Humana Inc. Valuation Multiples

Humana Inc. is valued at $50B as of October 2026, a 0.4x revenue multiple. In the last 12 months, Humana Inc. revenue was $156B and Humana Inc. EBITDA was $3.1B.

Humana Inc. Overview

About Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.


Founded

1964

HQ

United States

Employees

67.1K

Website

humana.com

Financials (LTM)

Revenue: $156B
EBITDA: $3.1B

EV

$57B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Humana Inc. Financials

Humana Inc. reported last 12-month revenue of $156B and EBITDA of $3.1B.

In the same LTM period, Humana Inc. generated $19B in gross profit, $3.1B in EBITDA, and $1.3B in net income.

Revenue (LTM)


Humana Inc. P&L

In the most recent fiscal year, Humana Inc. reported revenue of $130B and EBITDA of $3B.

Humana Inc. is profitable as of last fiscal year, with gross margin of 15%, EBITDA margin of 2%, and net margin of 1%.

See analyst estimates for Humana Inc.
LTMLast FY202320242025202620272028
Revenue$156B$130B$106B$118B$130B
Gross Profit$19B$19B--$19B
Gross Margin12%15%--15%
EBITDA$3.1B$3B--$3B
EBITDA Margin2%2%--2%
EBIT Margin2%3%--3%
Net Profit$1.3B$1.2B$2.5B$1.2B$1.2B
Net Margin1%1%2%1%1%
Net Debt-$8.2B---

Financial data powered by Morningstar, Inc.

Humana Inc. Stock Performance

Humana Inc. has current market cap of $50B, and enterprise value of $57B.

Market Cap Evolution


Humana Inc.'s stock price is $413.16.

Humana Inc. share price increased by 8.3% in the last 30 days, and by 48.5% in the last year.

Humana Inc. has an EPS (earnings per share) of $9.89.

See more trading valuation data for Humana Inc.
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$57B$50B0.0%8.3%13.5%48.5%$9.89

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Humana Inc. Valuation Multiples

Humana Inc. trades at 0.4x EV/Revenue multiple, and 18.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Humana Inc.

EV / Revenue (LTM)


Humana Inc. Financial Valuation Multiples

As of October 18, 2026, Humana Inc. has market cap of $50B and EV of $57B.

Humana Inc. has a P/E ratio of 38.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.4x0.4x0.5x0.5x0.4x
EV/EBITDA18.2x18.9x--18.9x
EV/EBIT22.9x16.9x--16.9x
EV/Gross Profit2.9x3.0x--3.0x
P/E38.2x41.8x19.9x41.1x41.8x
EV/FCF22.5x152.1x19.2x23.9x152.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Humana Inc. Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Humana Inc. Margins & Growth Rates

Humana Inc. grew revenue by 25% but EBITDA decreased by 4% in the last fiscal year.

In the most recent fiscal year, Humana Inc. reported gross margin of 15%, EBITDA margin of 2%, and net margin of 1%.

See estimated margins and future growth rates for Humana Inc.

Humana Inc. Margins

Last FY202420252026202720282029
Gross Margin15%-15%12%
EBITDA Margin2%-2%2%
EBIT Margin3%-3%1%
Net Margin1%1%1%1%
FCF Margin0%2%0%2%

Humana Inc. Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth25%11%10%25%
Gross Profit Growth3%--3%
EBITDA Growth(4%)--(4%)
EBIT Growth(33%)--(33%)
Net Profit Growth(7%)(52%)(2%)(7%)
FCF Growth670%(20%)(84%)670%

Data powered by FactSet, Inc. and Morningstar, Inc.

Humana Inc. Operational KPIs

Humana Inc.'s revenue per employee in the last FY averaged $1.9M.

Humana Inc.'s Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Humana Inc.'s Rule of X is 65% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Humana Inc.
LTMLast FY202620272028
Rule of 409%27%
Bessemer Rule of X19%65%
Revenue per Employee-$1.9M

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Cathay Financial Holdings$13B-3.2x3.9x--
Life Insurance Corporation of India$102B$6.1B0.5x0.5x7.7x8.3x
MS&AD Insurance Group$94B$7.4B0.5x1.0x5.9x7.0x
People's Insurance Co$97B$12B0.9x0.9x7.1x7.6x
Sun Life$27B$3.8B1.7x7.0x12.2x11.1x
PICC Property & Casualty$77B$7.9B0.7x0.6x6.4x5.5x
AIG$27B$7.7B2.0x1.9x6.9x10.1x
Daiichi Life Group$67B$5.3B0.9x0.8x10.7x12.2x

This data is available for Pro users. Sign up to see all Humana Inc. competitors and their valuation data.

Start Free Trial

Acquisitions by Humana Inc.

Humana Inc. has acquired 7 companies to date.

Last acquisition by Humana Inc. was on August 12th 2022. Humana Inc. acquired Inclusa for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Humana Inc.

Inclusa
onehome
Kindred at Home
iCare
Description
-
onehome is a Denver-based provider of coordinated home health services focusing on post-acute care transitions. The platform connects patients with nurse practitioners, therapists, and aides for in-home monitoring and recovery support, reducing hospital readmissions for Medicare beneficiaries aging 65 and older.
Kindred at Home is a Louisville, Kentucky-headquartered provider of home-based skilled nursing and rehabilitation services. Founded in 1985, it coordinates care to prevent hospital readmissions and offers personal assistance for non-medical needs. The company serves patients across 40 states through local agencies.
iCare is a Michigan-based managed care organization administering Medicaid health plans for aged, blind, and disabled residents. The plan covers long-term services, home health, behavioral health, and pharmacy benefits through networks of hospitals, physicians, and nursing facilities. Headquartered in Okemos, iCare serves enrollees in Wayne, Oakland, and Macomb counties with care coordination and disease management programs.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
-
Pensacola, FL
Louisville, KY
Milwaukee, WI
Deal Date12 Aug 202214 Jun 202127 Apr 20214 Dec 2020
Valuationundisclosedundisclosed$8.1Bundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Humana Inc. acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Humana Inc.

Humana Inc. has invested in 15 companies to date.

Latest investment by Humana Inc. was on September 2nd 2026. Humana Inc. invested in Thyme Care in their $125M Series E round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Humana Inc.

Thyme Care
Thyme Care
Main Street Health
Monogram Health
Description
Thyme Care is a New York-based oncology care management company partnering with health plans to deliver integrated support for cancer patients. The platform coordinates navigation, symptom management, psychosocial care, and financial assistance across 20 US states. Thyme Care's clinicians collaborate with oncologists at over 100 provider sites, using data analytics to personalize care journeys for members of payers like Aetna and Cigna. Founded in 2020, the company has enrolled thousands of patients in its whole-person care model.
Thyme Care is a New York-based oncology care management company partnering with health plans to deliver integrated support for cancer patients. The platform coordinates navigation, symptom management, psychosocial care, and financial assistance across 20 US states. Thyme Care's clinicians collaborate with oncologists at over 100 provider sites, using data analytics to personalize care journeys for members of payers like Aetna and Cigna. Founded in 2020, the company has enrolled thousands of patients in its whole-person care model.
Main Street Health is a value-based healthcare company, founded in 2021 and based in Nashville, Tennessee, that partners exclusively with rural primary care clinics in the United States. It places Health Navigators inside partner clinics and provides data and tools that help those clinics manage Medicare patients under value-based care, working with clinics that on average have 2.5 providers in towns of 3,000 to 5,000 people. The company has reported improvements in quality scores alongside reductions in hospitalizations and medical costs among the patient populations it serves.
Monogram Health is a Nashville-based value-based care provider specializing in in-home services for chronic kidney disease and end-stage renal disease patients. Operating across 34 states, it partners with health plans like UnitedHealthcare and Humana to deliver complex case management, medication therapy, and utilization review through its technology platform. Founded in 2018, the company employs nephrologists and care coordinators for evidence-based interventions that extend time to dialysis and reduce hospitalizations. Monogram serves Medicare Advantage and Medicaid populations with remote monitoring and 24/7 support.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Nashville, TN
Nashville, TN
-
-
Deal Date2 Sep 202625 Sep 20258 Oct 20239 Jan 2023
RoundSeries ESeries DUndisclosed stageSeries C
Raised$125M$97M$315M$375M
InvestorsHealthQuest Capital; Frist Cressey Ventures; Humana Inc.; Concord Health Partners; Town Hall Ventures; Foresite Capital; Andreessen Horowitz; CVS Health Ventures; Morgan Health; AlleyCorpFrist Cressey Ventures; Humana Inc.; Concord Health Partners; Town Hall Ventures; Foresite Capital; Andreessen Horowitz; Texas Oncology Physicians Association; CVS Health Ventures; Morgan Health; Memorial Hermann Health System; AlleyCorpHumana Inc.; CVS Health; Elevance Health; UnitedHealthcare; LRVHealth; Oak HC/FT; Echo Health Ventures; CenteneFrist Cressey Ventures; Humana Inc.; CVS Health; Heritage Group; Norwest; Cigna Ventures; TPG; Memorial Hermann Health System; Pura Vida Investments; Scan
Valuation$2B$1B$1.5Bundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Humana Inc. investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Humana Inc.

When was Humana Inc. founded?Humana Inc. was founded in 1964.
Where is Humana Inc. headquartered?Humana Inc. is headquartered in United States.
How many employees does Humana Inc. have?As of today, Humana Inc. has over 67K employees.
Who is the CEO of Humana Inc.?Humana Inc.'s CEO is James A. Rechtin.
Is Humana Inc. publicly listed?Yes, Humana Inc. is a public company listed on NYSE.
What is the stock symbol of Humana Inc.?Humana Inc. trades under HUM ticker.
When did Humana Inc. go public?Humana Inc. went public in 1971.
Who are competitors of Humana Inc.?Humana Inc. main competitors include Cathay Financial Holdings, Life Insurance Corporation of India, MS&AD Insurance Group, People's Insurance Co, Sun Life, PICC Property & Casualty, AIG, Daiichi Life Group, Great-West Lifeco, Power Corporation of Canada.
What is the current market cap of Humana Inc.?Humana Inc.'s current market cap is $50B.
What is the current revenue of Humana Inc.?Humana Inc.'s last 12 months revenue is $156B.
What is the current revenue growth of Humana Inc.?Humana Inc. revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Humana Inc.?Current revenue multiple of Humana Inc. is 0.4x.
What is the current EBITDA of Humana Inc.?Humana Inc.'s last 12 months EBITDA is $3.1B.
What is Humana Inc.'s EBITDA margin?Humana Inc.'s last 12 months EBITDA margin is 2%.
What is the current EV/EBITDA multiple of Humana Inc.?Current EBITDA multiple of Humana Inc. is 18.2x.
What is the current FCF of Humana Inc.?Humana Inc.'s last 12 months FCF is $2.5B.
What is Humana Inc.'s FCF margin?Humana Inc.'s last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Humana Inc.?Current FCF multiple of Humana Inc. is 22.5x.
How many companies Humana Inc. has acquired to date?As of October 2026, Humana Inc. has acquired 7 companies.
What was the largest acquisition by Humana Inc.?$8.1B acquisition of Kindred at Home on 27th April 2021 was the largest M&A Humana Inc. has done to date.
What companies Humana Inc. acquired?Humana Inc. acquired Kindred at Home, Kindred Healthcare, Enclara Pharmacia, FPG (family physicians group), Inclusa, onehome, and iCare.
In how many companies Humana Inc. has invested to date?As of October 2026, Humana Inc. has invested in 15 companies.
What was the last Humana Inc. investment?On 2nd September 2026 Humana Inc. invested in Thyme Care, participating in a $125M Series E round at $2B valuation, alongside HealthQuest Capital, Frist Cressey Ventures, Concord Health Partners, Town Hall Ventures, Foresite Capital, Andreessen Horowitz, CVS Health Ventures, Morgan Health, and AlleyCorp.
In what companies Humana Inc. invested in?Humana Inc. invested in Monogram Health, DispatchHealth, Main Street Health, Thyme Care, Iora Health, Heal, Oak Street Health, Omada Health, Livongo, Buoy Health, ClearDATA, Aspen RxHealth, Accolade, Circulation, and Cohere Health.

See public comps similar to Humana Inc.

Lists including Humana Inc.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial